About this trial
Through prospective registration and follow-up, this study will collect data of patients with intracranial/carotid stenosis, including clinical information, neuropsychological scales, multimodal magnetic resonance images. The investigators aim to analyze clinical and imaging characteristics of patients with cognitive impairment related to intracranial/carotid stenosis, in order to achieve early identification of cognitive impairment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged ≥ 40 years
≥ 50% stenosis in unilateral intracranial / carotid artery
Written informed consent available
Disqualifiers
Previous history of major head trauma and any intracranial surgery
Intracranial abnormalities, such as intracerebral hemorrhage, subarachnoid hemorrhage and other space occupying lesions
Extrapyramidal symptoms or mental illness which may affect neuropsychological measurement
Severe loss of vision, hearing, or communicative ability
Trial population
Patients with intracranial / carotid stenosis aged ≥ 40 years
Trial design
Cohort
Prospective
Treatments tested in this trial
standard medical treatment
Drugstandard medical treatment
Interventional stenting
Procedure/SurgeryInterventional stenting
Treatment groups
Trial outcomes
Primary outcomes
Changes in the scores of Mini-mental State Examination
Total score of 30. Higher scores mean a better outcome.
Secondary outcomes
Incidence of stroke event including ischemic and hemorrhagic stroke
Changes in cerebral glymphatic function
assessed by non-invasive diffusion tensor image analysis along the perivascular space (ALPS-index)
Changes in the scores of Montreal Cognitive Assessment
Total score of 30
Changes in cerebral blood flow in the territory of the culprit artery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.